|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy. Contents
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter.
Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.
Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.
OCR for page R5
Research Strategies for Assessing Adverse Events Associated withVaccines:: A Workshop Summary
Contents
INTRODUCTION AND BACKGROUND
1
CASE REPORTS AND PASSIVE SURVEILLANCE
2
Introduction
2
Discussion,
4
Suggested Improvements,
4
Data Analysis,
5
Signal Detection and Hypothesis Generation,
6
Use of Case Reports in Causality Assessment,
8
Education of Health Care Providers,
9
Vaccine Injury Compensation Program,
9
Evaluation of Passive Surveillance Systems,
9
LARGE-LINKED DATABASES
10
Introduction,
10
Discussion,
12
Strengths and Weaknesses of LLDBs,
12
Case Definitions,
13
Evaluation of LLDBs,
13
CLINICAL TRIALS
14
Introduction,
14
Discussion,
14
Randomization,
15
Standardization,
15
Participation in Clinical Trials,
16
Ethical Issues,
16
OTHER TOPICS
16
Unvaccinated Controls,
16
Background Incidence Rates,
17
Adverse Events with Long Latencies,
18
OCR for page R6
Research Strategies for Assessing Adverse Events Associated withVaccines:: A Workshop Summary
Multifactorial Etiologies,
19
Need for Basic Research,
19
SUMMARY
20
REFERENCES
20
ACRONYMS
21
WORKSHOP PARTICIPANTS
22
